Nov. 30, 2004 — The U.S. Food and Drug Administration (FDA) and King Pharmaceuticals, Inc., have notified healthcare professionals via letter of labeling changes for existing prescribing and route of ...

As syphilis cases continue to spike across the U.S. — with some cities and states recently reporting outbreaks — there is a growing concern about the availability of Bicillin, the injectable ...

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...

The preferred antibiotic treatment for syphilis is in short supply across the United States as infections soar, and more than three dozen leading public health groups are urging the White House to ...

Clinicians across the United States are rationing the only long-acting penicillin approved for syphilis treatment after the manufacturer pushed its next delivery of Bicillin L-A to October 2026 and ...

Incidence of serious sexually transmitted disease at 27-year high and demand for preferred antibiotic is straining manufacture Record-high rates of syphilis and an accompanying shortage of the ...

(CNN) — Pfizer, the manufacturer of Bicillin – a long-acting injectable form of the antibiotic penicillin – is warning doctors that it expects to run out of its formulations for children by the end of ...